In less than a decade, uterus transplantation has transformed the fields of reproductive medicine and transplantation-not only by presenting the first available treatment for uterine-factor infertility but also by being the first temporary organ transplant and an addition to the group of quality-of-life-enhancing organ transplants.
| INTRODUC TI ON
In less than a decade, uterus transplantation has transformed the fields of reproductive medicine and transplantation-not only by presenting the first available treatment for uterine-factor infertility but also by being the first temporary organ transplant and an addition to the group of quality-of-life-enhancing organ transplants.
The first baby born to a uterus-transplanted woman was delivered in 2014, and that birth has been followed by the births of 7 additional healthy babies. 1 As of yet, proof of concept for uterus transplantation has only been achieved with living directed donors at a single center in Sweden. 2 Of the 9 cases of live donor uterus transplantation in Sweden, each of the donors had either a genetic or emotional relationship with the recipient, which included both relatives and friends, and most donors were the mother of the recipient. 2 Altruistic or nondirected living organ donation is used worldwide for a variety of organ transplants, most frequently kidney and liver.
We suggest that 2 key elements have to be fulfilled in nondirected donors: the donor typically does not know any identifying details
Of the 62 potential donors who underwent initial screening, 74%
were nondirected. The majority of the donors were screened out during the initial phase of the evaluation process. 5 The main reasons for not proceeding were either that the donor did not meet the basic inclusion criteria of the trial, self-withdrawal, or comorbidities. 5 None of the donors or recipients were excluded based on the psychological evaluation (in-depth interview and standardized psycho-
logical questionnaires). Of the 8 potential donors (all nondirected)
who progressed through the screening process to be presented to the selection committee, 6 were chosen for uterus donation and had their uterus removed. Of the 2 donors who were screened out in the selection committee, 1 was considered not suitable due to prior history of obesity and the other was put on hold due to self-request.
Only donors considered absolutely medically and psychologically healthy were considered for donation.
| Donor characteristics
As shown in 
Religion (n)
No preference 2
Christian 4
Geographic origin (miles from transplant center)
<25 2
25-50 3
>50 1

Education level (n)
Bachelor's degree 4
Master's degree 2
Employment (n)
Not employed 1
Full-time 5
Profession (n)
Nurse 5
Yearly household income (n) degree, and 2 had a master's degree. The donor who was not a nurse attempted nursing school but did not finish. All of the donors had previous children (mean 3) and had completed their own family. All donors were nondirected.
| Psychological assessment
| Clinical interview
Each donor participated in a clinical interview with a psycholo- 
| Assessment measures
Assessment measures for this study were chosen based on use of similar assessment measures in the Swedish trial, including the Hospital Anxiety and Depression Scale (HADS) and the SF-36.
7
Other assessment measures were chosen to assess psychological resilience, personality and coping styles, substance use, and posttraumatic stress symptoms. Two of the assessment measures, the Million Behavioral Medicine Diagnostic and the Brief COPE, were not included in the current assessment but will be planned for analysis in a later article.
Hospital Anxiety and Depression Scale (HADS)
HADS was used as a measure of anxiety and depression. This measure is a 14-item scale normed on general hospital patients, 8 with The SF-36 is a commonly used measure to assess health-related quality of life in medical patients, including directed uterus donors.
2
The SF-36 provides 2 summary scores, the Physical Component
Summary and Mental Health Component Summary, each with a mean of 50 and a standard deviation of 10.
Connor Davidson Resilience Scale 10-Item (CD-RISC 10)
The CD-RISC 10 uses a 5-point range of responses from 0, "not true at all," to 4, "true nearly all the time," to measure patients' ability to tolerate experiences including change, pressure, failure, and difficult feelings, all believed to contribute to resilience. 11 The CD RISC 10 has been used in a large number of studies examining medical populations, including organ donors, 10 in which the original 25-item version was used. A mean score of 32 was identified in a community sample of 764 respondents.
12
Drug Abuse Screening Test (DAST-10)
The DAST-10 12 is a self-reported instrument assessing drug use over the past 12 months. Scores range from 0 to 10, with scores of 0 considered no risk; 1 to 2, low risk with monitoring and later reassessment; and ≥3, high-risk substance use. The DAST-10 is commonly used in medical settings, including organ donors. Alcohol and tobacco use, which is not assessed by the DAST-10, was reviewed during the clinical interview.
| RE SULTS
| Motivation for donation
Using open-ended questions, the participants were asked their reasons for wanting to be involved in the study trial. All of the participants gave more than 1 answer, with the number of reasons ranging from 2 to 5. The most common response that each donor gave when asked why she wanted to donate her uterus was the desire for another woman to carry her own child (n = 6). Table 2 .
| Mental health data
Participants in the study had varying current and past mental health histories, from no mental health history to past or current mental health history. Current mental health history would include someone who reports a current diagnosis or symptoms undergoing treatment. In all cases of past history, length of time ranged from 5 to over 20 years in the past. Data on current and past mental health history is seen in Table 3 . Table 4 outlines current and past treatment intervention. Positive psychological function, as measured by the CD-RISC 10, indicated that 6 of the participants' scores were the same as or higher than community population norms (ie, 32-40), with 1 subject scoring 30, below the population mean. As would be expected for inclusion in the study, none of the participants indicated any substance use on the DAST-10; all 6 had a score of 0. Health-related quality of life was measured using the SF-36 (Table 6 ). Although inference is hindered by the small sample size, Hedges' g with unpooled standard deviations, which accounts for differences in sample sizes and variances, indicated the study sample was healthier than the normative sample on all scales with moderate to large effects. 13 
| Psychological assessment data
| D ISCUSS I ON
Uterus transplantation embodies not only hope, but also the first available treatment for the many women with uterine-factor infertility. The novel procedure intersects in a unique way between the fields of transplantation, reproductive medicine, and restorative medicine and has huge potential benefits if successful. Studies of
TA B L E 2 Reasons for uterus donation
Reason Donors
Desire for a woman to carry a child of her own 6
Wanting to contribute to science 2
Already an organ donor/past history of donation 3
Desire to help others/give back 4
Consistent with chosen profession (nursing) 3
Previously considered acting as a surrogate 1
Knowledge/interest in the previous study trials of uterus transplant 2
No longer needs uterus 1 In the absence of a relationship between the donor and recipient, the motives and psychological functioning of the donor are of specific interest. Our study showed great interest from nondirected living donors in donating their uterus for transplantation. Among our selected donors, the desire for another woman to carry her own child was singled out as the greatest motivator for donation, followed by a desire to contribute to science and to help others. The desire to help others has also been shown to be the primary donation motivator for living kidney donors, directed and nondirected alike.
TA B L E 3 Mental health history
TA B L E 4 Mental health intervention history
14-16
Studies in living kidney donors have shown that there is no significant difference in personality, psychosocial outcomes, physical outcomes, or regret between nondirected kidney donors and directed kidney donors. 15 In addition, it has been shown that nondirected living kidney donors recover more quickly from surgery. 15 Compared to the living uterus donor population in Sweden, 2 the mean age of our reported also in the United Kingdom. 18, 19 The somewhat surprising outcome that the majority of our nondirected donors were nurses can at least partly be explained by the fact that since we chose to not actively recruit donors or recipients, our uterus transplant trial was mainly known by healthcare staff members. In addition, it can be assumed that nurses in general are well familiar with and have a trust in the healthcare system and have a professional devotion to help others. As the majority of the potential donors from the larger screening pool were also in the nursing or healthcare field, we do not believe there was a selection bias in the chosen donors.
Half of the donors in the study reported depression or anxiety in the past, and in clinical interview it appeared most developed symptoms following a major life event such as bereavement due to loss of a loved one, relationship conflict, and divorce. Outside of this, the only other mental health issue was 1 donor who was diagnosed with Attention Deficit Hyperactivity Disorder. Although 1 donor did have elevations on the PCL-5, she did not meet the criteria for PTSD, and this was directly associated with a specific traumatic event that had occurred over a year prior. This was the same participant who was involved in both regular psychotherapy with a clinical psychologist as well as medication from a psychiatrist. In this case, her providers were asked to comment on the participant's suitability for study participation, and neither indicated participation in the study would be of concern. Four donors reported either past and/or current treatment for mental health symptoms (either psychotherapy or psychotropic medication).
In the United States, almost 50% of adults will have a mental illness during their lifetime, with anxiety disorder occurring in 18.1%
of adults and major depressive disorder occurring in 6.7%. universal desire on the part of all participants to give another woman an opportunity to carry their own child likely speaks to the positive psychological experience of pregnancy, regardless of whether or not history or mental health issues were present. Despite this, careful consideration was given with each donor to assess the level and quality of support from the donor's social network and her likely resilience in managing potential complications. Even if all donors were considered stable and well adjusted, according to both the psychological assessments and the in-depth-interviews, compared with the general population at inclusion in the transplantation trial, it was decided that close monitoring was to take place during the donation process.
As has been shown in other living donor studies, the experience of providing an organ to someone else may in fact have a benefit on mental health. In a Dutch study of living kidney donors, almost half of the donors had a history of depression before donation. 14 The psychological complaints were within the average range both before and after donation. The subjective impact on psychological well-being of the donation experienced by the donors was very positive, and satisfaction with donation was high. Also, in nondirected living kidney donors, no lasting psychosocial or functional concerns have been
shown after a median of 5 years after donation (range, 1-12 years). 16 We also found that our nondirected donor participants had higher health-related quality of life than the general population using the SF-36 scales, and this was seen across the scales, includ- Whether it is appropriate to pursue living donor uterus transplantation, with the risk of harm to the living donor, before the deceased donor option has been fully explored, has been debated. 22 Due to scarcity of organs, society has determined the risk-benefit ratio to be acceptable at the present complication rate for living kidney and liver donors. 23 Motivation to provide an organ for a non-lifesaving reason would, though, potentially appear to be more understandable when a genetic or emotional relationship exists. For the lifesaving organs, it is understood that potential donors (both directed and nondirected), given that they are fully informed and capable of giving consent, can weigh the benefits and risks for themselves. 23 Unlike the kidney or liver, the uterus at donation no longer has any function for the donor. Furthermore, a recent meta-analysis of women seeking hysterectomy for benign gynecological issues was not associated with worse depression or anxiety postoperatively and in fact found less depression symptoms after uterus removal. 24 Thus, the loss of the uterus is not anticipated to cause any future medical or psychological risks to the donor. Putting aside the possible surgical complications, it could be argued that living uterus donation poses a lesser ethical dilemma than that of living liver or kidney donation. 25 
| CON CLUS ION
Nondirected living organ donation is still controversial and even more so when it comes to transplantation of non-lifesaving, but quality-of-life-enhancing, organs like the uterus. This is the first described cohort of nondirected living uterus donors. Further research on the potential psychological motives and gains for the donor as well as long-term effects on donors is crucial for ethical practice.
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